Dr. Leyden is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
2 Rhoads Pavilion
Philadelphia, PA 19104Phone+1 215-662-2737Fax+1 215-349-8339
Education & Training
- University of Pennsylvania Health SystemResidency, Dermatology, 1967 - 1972
- Temple University HospitalInternship, Internal Medicine, 1966 - 1967
- Perelman School of Medicine at the University of PennsylvaniaClass of 1966
Certifications & Licensure
- PA State Medical License 1967 - 2024
- American Board of Dermatology Dermatology
Clinical Trials
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne Start of enrollment: 2009 Sep 01
- A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers Start of enrollment: 2012 Nov 01
Publications & Presentations
PubMed
- 7 citationsA pilot methodology study for the photographic assessment of post-inflammatory hyperpigmentation in patients treated with tretinoinAna B. Rossi, James J. Leyden, AS Pappert, A Ramaswamy, Alex Nkengne
Journal of the European Academy of Dermatology and Venereology. 2011-04-01 - 8 citationsLow serum iron levels and moderate anemia in severe nodulocystic acne. Reversal with isotretinoin therapy.James J. Leyden
Archives of Dermatology. 1985-02-01 - 166 citationsPractical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in AcneDiane Thiboutot, Brigitte Dréno, Abdullah Abanmi, Andrew F Alexis, Elena Araviiskaia
Journal of the American Academy of Dermatology. 2018-02-01
Press Mentions
- Psoriasis Patients Can Get Clearer Skin with at-Home Treatment Instead of at Doctors' Offices, Study SuggestsOctober 26th, 2024
- Tretinoin Review with Newer Formulations: Providing Effective and Tolerable Solutions in Clinical PracticeJanuary 1st, 2023
- Penn Research Finds Psoriasis Medication Apremilast Leads to Fat Loss in People with PsoriasisSeptember 21st, 2022
- Join now to see all
Grant Support
- Accutane NF And Oral Contraceptive Tablets In Premenopausal Women W Nodular AcneNational Center For Research Resources2000–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: